Chimerix Inc (CMRX) is looking forward to a strong quarter

With 2.73 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.24 million shares. The 52-week range on CMRX shows that it touched its highest point at $8.47 and its lowest point at $0.75 during that stretch. It currently has a 1-year price target of $8.54. Beta for the stock currently stands at -0.17.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CMRX was up-trending over the past week, with a rise of 70.36%, but this was up by 100.71% over a month. Three-month performance surged to 882.56% while six-month performance rose 864.61%. The stock gained 570.63% in the past year, while it has gained 142.82% so far this year. A look at the trailing 12-month EPS for CMRX yields -0.94 with Next year EPS estimates of -1.16. For the next quarter, that number is -0.26. This implies an EPS growth rate of -6.24% for this year and -17.41% for next year. EPS is expected to grow by 9.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 8.31%.

Float and Shares Shorts:

At present, 89.94 million CMRX shares are outstanding with a float of 78.69 million shares on hand for trading.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.94808 being high and -$1.02792 being low. For CMRX, this leads to a yearly average estimate of -$0.988. Based on analyst estimates, the high estimate for the next quarter is -$0.29 and the low estimate is -$0.29. The average estimate for the next quarter is thus -$0.29.